DefiniGEN is a contract research organization (CRO) that specializes in liver and metabolic disease models using iPSC-derived technology. The company provides cell-based models for drug discovery and development.
Stemnovate is a pioneering company focused on building animal models for drug discovery in the pharmaceutical and animal health industries.
Company Details
DefiniGEN is operated by Pixl Bio Ltd and is a Active company incorporated on 7 April 2011 with the registered office located in Cambridge, Cambridgeshire. Pixl Bio Ltd was registered 14 years ago.